Skip to main content
Research

Publications: Mr Thomas Moseley

Arokiasamy S, Balderstone MJM, Shaik F, Cristante E, Moseley TC, Madoo A, Rizzi M, Bainbridge JW et al. ( 2024 ) . QM107, a novel CD148 (RTP Type J) activating peptide therapy for treating neovascular ageā€related macular degeneration . British Journal of Pharmacology